Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD123 ( clone I4RB36). We employs the Adenovirus (CMV-Cy5-IL-4-HindIII) vector components and the SynExpress system of the exons Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
human
Target
CD123
Clone
I4RB36
Species Reactivity
human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Prime Editing
Modification Domain
Exons
Carrier Type
Adenovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.